Thrive Wealth Management, LLC

Position in AMGN — Amgen Inc

CIK 1847610 AUDUBON, PA

Position in AMGN

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$1,165,302

+$23,197 QoQ

Shares Held

3,218

-0.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.56%

of 13F equity value

Holder Rank

#1,601

of 3,140 holders

Holding Since

Jun 2022

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Thrive Wealth Management, LLC holds $13,579,206 across 8 Drug Manufacturers - General names. AMGN ranks #5 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	22,510	$5,716,864
2	MRK	Merck & Co., Inc.	18,054	$2,319,939
3	LLY	ELI LILLY & Co	1,255	$1,505,284
4	ABBV	AbbVie Inc.	5,708	$1,436,361
5	AMGN	Amgen Inc This page	3,218	$1,165,302
6	PFE	Pfizer Inc	28,655	$690,012
7	AZN	Astrazeneca PLC	2,264	$429,299
8	GSK	GSK plc	6,031	$316,145

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,165,302	3,218	-0.9%	Shares	Sole	2026-07-07
2026-03-31	$1,142,105	3,246	-1.1%	Shares	Sole	2026-04-09
2025-12-31	$1,074,231	3,282	+0.9%	Shares	Sole	2026-01-12
2025-09-30	$918,278	3,254	-0.6%	Shares	Sole	2025-10-07
2025-06-30	$913,575	3,272	+14.7%	Shares	Sole	2025-07-09
2025-03-31	$888,540	2,852	-1.2%	Shares	Sole	2025-04-10
2024-12-31	$752,728	2,888	+0.5%	Shares	Sole	2025-01-16
2024-09-30	$926,353	2,875	+0.7%	Shares	Sole	2024-10-04
2024-06-30	$891,732	2,854	+3.0%	Shares	Sole	2024-07-12
2024-03-31	$788,135	2,772	+18.7%	Shares	Sole	2024-04-16
2023-12-31	$672,814	2,336	+0.0%	Shares	Sole	2024-01-10
2023-09-30	$627,554	2,335	+8.7%	Shares	Sole	2023-10-13
2023-06-30	$476,898	2,148	-5.4%	Shares	Sole	2023-07-12
2023-03-31	$549,014	2,271	+34.1%	Shares	Sole	2023-04-07
2022-12-31	$444,912	1,694	+18.5%	Shares	Sole	2023-01-25
2022-09-30	$322,096	1,429	+17.5%	Shares	Sole	2022-10-24
2022-06-30	$295,852	1,216	—	Shares	Sole	2022-07-11
No filing history on record for this holder in this stock.